verapamil has been researched along with Anemia, Sickle Cell in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stuart, J | 1 |
| Mojiminiyi, FB | 1 |
| Stone, PC | 1 |
| Culliford, SJ | 1 |
| Ellory, JC | 1 |
| Ohnishi, ST | 1 |
| Horiuchi, KY | 1 |
| Horiuchi, K | 1 |
| Jurman, ME | 1 |
| Sadanaga, KK | 1 |
2 other studies available for verapamil and Anemia, Sickle Cell
| Article | Year |
|---|---|
Additive in vitro effects of anti-sickling drugs.
Topics: Anemia, Sickle Cell; Antisickling Agents; Benzaldehydes; Calcium; Cells, Cultured; Clotrimazole; Dru | 1994 |
Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells.
Topics: Adult; Anemia, Sickle Cell; Calcium; Calcium Channel Blockers; Calmodulin; Dehydration; Erythrocytes | 1986 |